Tvardi Therapeutics, Inc.
TVRD
$1.85
-$0.09-4.64%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 15.77M | 24.98M | 30.81M | 36.46M | 40.99M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.30M | 345.00K | 727.00K | 1.98M | 2.14M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 17.07M | 25.33M | 31.54M | 38.44M | 43.13M |
|
|
|||||
| Total Current Assets | 17.07M | 25.33M | 31.54M | 38.44M | 43.13M |
| Net Property, Plant & Equipment | 140.00K | 168.00K | 196.00K | 223.00K | 249.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 291.00K | 306.00K | 322.00K | 338.00K | 354.00K |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 17.00K | 17.00K | 17.00K | 17.00K | 17.00K |
| Total Assets | 17.52M | 25.82M | 32.07M | 39.02M | 43.75M |
|
|
|||||
| Total Accounts Payable | 4.64M | 4.62M | 3.22M | 4.08M | 2.43M |
| Total Accrued Expenses | 4.35M | 6.52M | 7.71M | 6.85M | 8.14M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 123.00K | 120.00K | 116.00K | 113.00K | 109.00K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 9.11M | 11.26M | 11.04M | 11.04M | 10.68M |
|
|
|||||
| Total Current Liabilities | 9.11M | 11.26M | 11.04M | 11.04M | 10.68M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 22.00K | 54.00K | 85.00K | 115.00K | 145.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 9.14M | 11.31M | 11.13M | 11.16M | 10.82M |
|
|
|||||
| Common Stock & APIC | 132.09M | 131.76M | 131.39M | 131.03M | 130.59M |
| Retained Earnings | -123.71M | -117.25M | -110.45M | -103.18M | -97.65M |
| Treasury Stock & Other | -- | 1.00K | 8.00K | 7.00K | -13.00K |
| Total Common Equity | 8.38M | 14.51M | 20.95M | 27.87M | 32.93M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 8.38M | 14.51M | 20.95M | 27.87M | 32.93M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 8.38M | 14.51M | 20.95M | 27.87M | 32.93M |
|
|
|||||